PUBLIC CONTRACT · 2024
Aquisição de ABACAVIR 600 MG + LAMIVUDINA 300 MG e DOLUTEGRAVIR 50 MG + RILPIVIRINA 25 MG COMP
- Contract value
- €15,087.00
- Signed on
- 12 December 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11092240PUBLISHED SUBJECT
Aquisição de ABACAVIR 600 MG + LAMIVUDINA 300 MG e DOLUTEGRAVIR 50 MG + RILPIVIRINA 25 MG COMP
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GENERIS – FARMACEUTICA, S.A. · Tax ID 508107997
- Bidder
- VIIVHIV HEALTHCARE, UNIPESSOAL, LDA · Tax ID 509117961
- Bidder
- MYLAN, LDA. · Tax ID 502248793
Values and timeline
- Contract price
- €15,087.00
- Procedure base price
- €321,550.80
- Total effective price
- Not reported on Portal BASE
- Publication date
- 17 December 2024
- Award date
- 9 December 2024
- Signing date
- 12 December 2024
- Performance period
- 18 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 900/2024 - Concurso público internacional para formação do acordo quadro de medicamentos antirretrovíricos para o tratamento da infeção por VIH na área da saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7324560
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.